{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:15:03Z","timestamp":1789877703604,"version":"4.0.1"},"reference-count":56,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,5,1]]},"abstract":"<jats:p>Objective. The aim of this study was to assess vitamin K status in an unselected population of children with cystic fibrosis (CF) and to investigate any vitamin K effect on bone turnover and bone mineral status.<\/jats:p>\n                  <jats:p>Methods. Children \u22655 years of age who were attending the CF unit were invited to enter the study. Fasting blood samples were analyzed for levels of vitamin K1 and prothrombin produced in vitamin K absence; total, undercarboxylated, and carboxylated osteocalcin (OC); and bone-specific alkaline phosphatase and procollagen I carboxy-terminal propeptide (bone formation markers). Levels of N-telopeptide and free pyridinoline and deoxypyridinoline (bone breakdown products) were measured in urine samples. Bone mineral density and bone mineral content were measured at the lumbar spine and for the total body with a GE Lunar Prodigy densitometer. Statistical analyses were performed with Minitab version 9.1.<\/jats:p>\n                  <jats:p>Results. One hundred six children entered the study. Sixty-five of 93 children (70%) from whom blood samples were obtained showed suboptimal vitamin K status, on the basis of low serum vitamin K1 levels, increased prothrombin produced in vitamin K absence levels, or both abnormalities. Vitamin K1 levels showed a significant negative correlation with undercarboxylated OC levels but showed no significant correlation with any marker of bone turnover or measurement of bone mineral status. Undercarboxylated OC levels were correlated significantly with bone turnover markers, which themselves showed a significant negative correlation with measurements of bone mineral density and content. There were no significant correlations between carboxylated or undercarboxylated OC levels and bone density measurements.<\/jats:p>\n                  <jats:p>Conclusions. Vitamin K1 deficiency is common among children with CF, and routine supplements should be considered. Through its role in the carboxylation of OC, vitamin K deficiency may be associated with an uncoupling of the balance between bone resorption and bone formation. A cause-effect relationship between vitamin K deficiency and low bone mass has not been proved.<\/jats:p>","DOI":"10.1542\/peds.2004-1242","type":"journal-article","created":{"date-parts":[[2005,5,2]],"date-time":"2005-05-02T15:38:07Z","timestamp":1115048287000},"page":"1325-1331","source":"Crossref","is-referenced-by-count":95,"title":["Vitamin K Status Among Children With Cystic Fibrosis and Its Relationship to Bone Mineral Density and Bone Turnover"],"prefix":"10.1542","volume":"115","author":[{"given":"Steven P.","family":"Conway","sequence":"first","affiliation":[{"name":"Pediatric Cystic Fibrosis Unit, St James' University Hospital, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan P.","family":"Wolfe","sequence":"additional","affiliation":[{"name":"Pediatric Cystic Fibrosis Unit, St James' University Hospital, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith G.","family":"Brownlee","sequence":"additional","affiliation":[{"name":"Pediatric Cystic Fibrosis Unit, St James' University Hospital, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"White","sequence":"additional","affiliation":[{"name":"Pediatric Cystic Fibrosis Unit, St James' University Hospital, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Oldroyd","sequence":"additional","affiliation":[{"name":"Centre for Bone and Body Composition Research, University of Leeds, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Truscott","sequence":"additional","affiliation":[{"name":"Centre for Bone and Body Composition Research, University of Leeds, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia M.","family":"Harvey","sequence":"additional","affiliation":[{"name":"Haemophilia Reference Centre, St Thomas' Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Shearer","sequence":"additional","affiliation":[{"name":"Haemophilia Reference Centre, St Thomas' Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2005,5,1]]},"reference":[{"key":"2021120819252166500_R1","doi-asserted-by":"crossref","unstructured":"Booth SL, Suttie JW. Dietary intake and adequacy of vitamin K1. J Nutr.\u20081998;128:785\u2013788","DOI":"10.1093\/jn\/128.5.785"},{"key":"2021120819252166500_R2","doi-asserted-by":"crossref","unstructured":"Suttie JW. The importance of menaquinones in human nutrition. Annu Rev Nutr.\u20081995;15:399\u2013417","DOI":"10.1146\/annurev.nu.15.070195.002151"},{"key":"2021120819252166500_R3","doi-asserted-by":"crossref","unstructured":"Hauschka PV, Lian JB, Cole DEC, Gunberg CM. Osteocalcin and matrix Gla protein: vitamin K dependent proteins in bone. Physiol Rev.\u20081989;69:990\u20131047","DOI":"10.1152\/physrev.1989.69.3.990"},{"key":"2021120819252166500_R4","doi-asserted-by":"crossref","unstructured":"Vermeer C, Jie KS, Knapen MH. Role of vitamin K in bone metabolism. Annu Rev Nutr.\u20081995;15:1\u201322","DOI":"10.1146\/annurev.nu.15.070195.000245"},{"key":"2021120819252166500_R5","doi-asserted-by":"crossref","unstructured":"Suttie JW. Vitamin K and human nutrition. J Am Diet Assoc.\u20081992;92:585\u2013590","DOI":"10.1016\/S0002-8223(21)00681-7"},{"key":"2021120819252166500_R6","doi-asserted-by":"crossref","unstructured":"Shearer MJ. Vitamin K. Lancet.\u20081995;345:229\u2013234","DOI":"10.1016\/S0140-6736(95)90227-9"},{"key":"2021120819252166500_R7","doi-asserted-by":"crossref","unstructured":"Vermeer C, Knapen MHJ, Schurgers LJ. Vitamin K and metabolic bone disease. J Clin Pathol.\u20081998;51:424\u2013426","DOI":"10.1136\/jcp.51.6.424"},{"key":"2021120819252166500_R8","doi-asserted-by":"crossref","unstructured":"Gundberg CM, Nieman SD, Abrams S, Rosen H. Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab.\u20081998;83:3258\u20133266","DOI":"10.1210\/jc.83.9.3258"},{"key":"2021120819252166500_R9","doi-asserted-by":"crossref","unstructured":"Van Hoorn JH, Hendriks JJ, Vermeer C, Forget PP. Vitamin K supplementation in cystic fibrosis. Arch Dis Child.\u20082003;88:974\u2013975","DOI":"10.1136\/adc.88.11.974"},{"key":"2021120819252166500_R10","doi-asserted-by":"crossref","unstructured":"Booth SL, Martini L, Peterson JW, Saltzman E, Dallal GE, Wood RJ. Dietary phylloquinone depletion and repletion in older women. J Nutr.\u20082003;133:2565\u20132569","DOI":"10.1093\/jn\/133.8.2565"},{"key":"2021120819252166500_R11","doi-asserted-by":"crossref","unstructured":"Torstenson OL, Humphrey GB, Edson JR, Warwick WJ. Cystic fibrosis presenting with severe haemorrhage due to vitamin K malabsorption: a report of 3 cases. Pediatrics.\u20081970;45:857\u2013861","DOI":"10.1542\/peds.45.5.857"},{"key":"2021120819252166500_R12","doi-asserted-by":"crossref","unstructured":"Walters TR, Koch HF. Haemorrhagic diathesis and cystic fibrosis in infancy. Am J Dis Child.\u20081972;124:641\u2013642","DOI":"10.1001\/archpedi.1972.02110170019002"},{"key":"2021120819252166500_R13","doi-asserted-by":"crossref","unstructured":"Verghesse T, Beverley D. Vitamin K deficient bleeding in cystic fibrosis. Arch Dis Child.\u20082003;88:553","DOI":"10.1136\/adc.88.6.553"},{"key":"2021120819252166500_R14","doi-asserted-by":"crossref","unstructured":"Sokol RJ, Reardon MC, Accurso FJ, et al. Fat soluble vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns. Am J Clin Nutr.\u20081989;50:1064\u20131071","DOI":"10.1093\/ajcn\/50.5.1064"},{"key":"2021120819252166500_R15","doi-asserted-by":"crossref","unstructured":"Choonara IA, Winn MJ, Park BK, Littlewood JM. Plasma vitamin K1 concentrations in cystic fibrosis. Arch Dis Child.\u20081989;64:732\u2013734","DOI":"10.1136\/adc.64.5.732"},{"key":"2021120819252166500_R16","doi-asserted-by":"crossref","unstructured":"Cornelissen EA, van Lieburg AF, Motohara K, van Oostrom CG. Vitamin K status in cystic fibrosis. Acta Pediatr.\u20081992;81:658\u2013661","DOI":"10.1111\/j.1651-2227.1992.tb12327.x"},{"key":"2021120819252166500_R17","doi-asserted-by":"crossref","unstructured":"Corrigan JJ, Taussig LM, Beckerman R, Wagener JS. Factor II (prothrombin) coagulant activity and immunoreactive protein: detection of vitamin K deficiency and liver disease in patients with cystic fibrosis. J Pediatr.\u20081981;99:254\u2013257","DOI":"10.1016\/S0022-3476(81)80468-4"},{"key":"2021120819252166500_R18","doi-asserted-by":"crossref","unstructured":"de Montalembert M, Lenoir G, Saint'Raymond A, Rey J, Lefrere JJ. Increased PIVKA-II concentrations in patients with cystic fibrosis. J Clin Pathol.\u20081992;45:180\u2013181","DOI":"10.1136\/jcp.45.2.180"},{"key":"2021120819252166500_R19","unstructured":"Durie PR. Vitamin K and the management of patients with cystic fibrosis. Can Med Assoc J.\u20081994;151:933\u2013936"},{"key":"2021120819252166500_R20","doi-asserted-by":"crossref","unstructured":"Rashid M, Durie P, Andrew M, et al. Prevalence of vitamin K deficiency in cystic fibrosis. Am J Clin Nutr.\u20081999;70:378\u2013382","DOI":"10.1093\/ajcn\/70.3.378"},{"key":"2021120819252166500_R21","doi-asserted-by":"crossref","unstructured":"Wilson DC, Rashid M, Durie PR, et al. Treatment of vitamin K deficiency in cystic fibrosis: effectiveness of a daily fat-soluble vitamin combination. Pediatrics.\u20082001;138:851\u2013855","DOI":"10.1067\/mpd.2001.113633"},{"key":"2021120819252166500_R22","doi-asserted-by":"crossref","unstructured":"O'Shaughnessy D, Allen C, Woodcock T, Pearce K, Harvey J, Shearer M. Echis time, under-carboxylated prothrombin and vitamin K status in intensive care patients. Clin Lab Haematol.\u20082003;25:397\u2013404","DOI":"10.1046\/j.0141-9854.2003.00547.x"},{"key":"2021120819252166500_R23","doi-asserted-by":"crossref","unstructured":"Thane CW, Bates CJ, Shearer MJ, et al. Plasma phylloquinone (vitamin K1) concentration and its relationship to intake in a national sample of British elderly people. Br J Nutr.\u20082002;87:615\u2013622","DOI":"10.1079\/BJN2002582"},{"key":"2021120819252166500_R24","doi-asserted-by":"crossref","unstructured":"Belle M, Brebant R, Guinet R, Leclercq M. Production of a new monoclonal antibody specific to human des-\u03b3-carboxyprothrombin in the presence of calcium ions: application to the development of a sensitive ELISA-test. J Immunoassay.\u20081995;16:213\u2013229","DOI":"10.1080\/15321819508013559"},{"key":"2021120819252166500_R25","unstructured":"Belle M, Leclercq M, Vignal B, et al. Application of an ELISA test to vitamin K-deficient conditions using a new monoclonal antibody against human des-\u03b3-carboxy-prothrombins (DCP). In: Sutor AH, Hathaway WE, eds. Vitamin K in Infancy. Stuttgart, Germany: Schattauer; 1995:123\u2013137"},{"key":"2021120819252166500_R26","doi-asserted-by":"crossref","unstructured":"Usui Y, Tanimura H, Nishimura N, Kobayashi N, Okanoue T, Ozawa K. Vitamin K concentrations in the plasma and liver of surgical patients. Am J Clin Nutr.\u20081990;51:846\u2013852","DOI":"10.1093\/ajcn\/51.5.846"},{"key":"2021120819252166500_R27","doi-asserted-by":"crossref","unstructured":"Sokoll LJ, Sadowski JA. Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. Am J Clin Nutr.\u20081996;63:566\u2013573","DOI":"10.1093\/ajcn\/63.4.566"},{"key":"2021120819252166500_R28","doi-asserted-by":"crossref","unstructured":"Blanchard RA, Furie BC, Jorgensen M, Kruger SF, Furie B. Acquired vitamin K-dependent carboxylation deficiency in liver disease. N Engl J Med.\u20081981;305:242\u2013248","DOI":"10.1056\/NEJM198107303050502"},{"key":"2021120819252166500_R29","doi-asserted-by":"crossref","unstructured":"Ross PD, Knowlton W. Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res.\u20081998;13:297\u2013302","DOI":"10.1359\/jbmr.1998.13.2.297"},{"key":"2021120819252166500_R30","doi-asserted-by":"crossref","unstructured":"Weber P. Vitamin K and bone health. Nutrition.\u20082001;17:880\u2013887","DOI":"10.1016\/S0899-9007(01)00709-2"},{"key":"2021120819252166500_R31","doi-asserted-by":"crossref","unstructured":"Kanai T, Takagi T, Masuhiro K, Nakamura M, Iwata M, Saji F. Serum vitamin K level and bone mineral density in post-menopausal women. Gynaecol Obstet.\u20081997;56:25","DOI":"10.1016\/S0020-7292(96)02790-7"},{"key":"2021120819252166500_R32","doi-asserted-by":"crossref","unstructured":"Hodges SJ, Akesson K, Vergnau DP, Obrant K, Delmas PD. Circulating levels of vitamin K1 and K2 decreased in elderly women with hip fracture. J Bone Miner Res.\u20081993;8:1241","DOI":"10.1002\/jbmr.5650081012"},{"key":"2021120819252166500_R33","doi-asserted-by":"crossref","unstructured":"Tamatani M, Morimoto S, Nakajima M, et al. Decreased circulating levels of vitamin K and 25-hydroxyvitamin D in osteopenic elderly men. Metabolism.\u20081998;47:195\u2013199","DOI":"10.1016\/S0026-0495(98)90220-7"},{"key":"2021120819252166500_R34","doi-asserted-by":"crossref","unstructured":"Jie KS, Bots ML, Vermeer C, Witteman JCM, Grobbee DE. Vitamin K status and bone mass in women with and without aortic atherosclerosis: a population based study. Calcif Tissue Int.\u20081996;59:352","DOI":"10.1007\/s002239900139"},{"key":"2021120819252166500_R35","doi-asserted-by":"crossref","unstructured":"Szulc P, Chapuy MC, Menuier PJ, Delmas PD. Serum under-carboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest.\u20081993;91:1769\u20131774","DOI":"10.1172\/JCI116387"},{"key":"2021120819252166500_R36","doi-asserted-by":"crossref","unstructured":"Schoon EJ, Muller MCA, Vermeer C, Schurgers LJ, Brummer R-JM, Stockbrugger RW. Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease?Gut.\u20082001;48:473\u2013477","DOI":"10.1136\/gut.48.4.473"},{"key":"2021120819252166500_R37","doi-asserted-by":"crossref","unstructured":"Knapen MHJ, Hamulyak K, Vermeer C. The effect of vitamin K supplementation on circulating osteocalcin (bone GLA-protein) and urinary calcium excretion. Ann Intern Med.\u20081989;111:1001\u20131005","DOI":"10.7326\/0003-4819-111-12-1001"},{"key":"2021120819252166500_R38","doi-asserted-by":"crossref","unstructured":"Knapen MH, Jie KS, Hamulyak K, Vermeer C. Vitamin K induced changes in markers for osteoblast activity and urinary calcium loss. Calcif Tissue Int.\u20081993;53:81\u201385","DOI":"10.1007\/BF01321883"},{"key":"2021120819252166500_R39","doi-asserted-by":"crossref","unstructured":"Schaafsma A, Muskiet FA, Storm H, Hofstede GJ, Pakan I, Van der Veer E. Vitamin D3 and vitamin K1 supplementation of Dutch menopausal women with normal and low bone mineral densities: effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin. Eur J Clin Nutr.\u20082000;54:626\u2013631","DOI":"10.1038\/sj.ejcn.1601065"},{"key":"2021120819252166500_R40","doi-asserted-by":"crossref","unstructured":"Matsunaga S, Ito H, Sakou T. The effect of vitamin K and D supplementation on ovariectomy-induced bone loss. Calcif Tissue Int.\u20081999;65:285\u2013289","DOI":"10.1007\/s002239900700"},{"key":"2021120819252166500_R41","unstructured":"Bolton-Smith C, Mole PA, McMurdo MET, Paterson CR, Shearer MJ. Two-year intervention with phylloquinone (vitamin K1), vitamin D and calcium: effect on bone mineral content of older women. Ann Nutr Metab.\u20082001;45(suppl 1):46"},{"key":"2021120819252166500_R42","unstructured":"Department of Health. Report on Health and Social Subjects 41: Dietary Reference Values for Food, Energy, and Nutrition for the United Kingdom. London, United Kingdom: Her Majesty's Stationery Office; 1991"},{"key":"2021120819252166500_R43","unstructured":"Price R, Fenton S, Shearer MJ, Bolton-Smith C. Daily and seasonal variation in phylloquinone (vitamin K1) intake in Scotland. Proc Nutr Soc.\u20081996;55:244A"},{"key":"2021120819252166500_R44","doi-asserted-by":"crossref","unstructured":"Thane CW, Paul AA, Bates CJ, Bolton-Smith C, Prentice A, Shearer MJ. Intake and sources of phylloquinone (vitamin K1): variation with socio-demographic and lifestyle factors in a national sample of British elderly people. Br J Nutr.\u20082002;87:605\u2013613","DOI":"10.1079\/BJN2002583"},{"key":"2021120819252166500_R45","unstructured":"Food and Nutrition Board, Institute of Medicine. Vitamin K. In: Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Banadium, and Zinc. Washington, DC: National Academy Press; 2001:127"},{"key":"2021120819252166500_R46","doi-asserted-by":"crossref","unstructured":"Binkley NC, Krueger DC, Kawahara TN, Engelke JA, Chappell RJ, Suttie JW. A high phylloquinone intake is required to achieve maximal osteocalcin \u03b3-carboxylation. Am J Clin Nutr.\u20082002;76:1055\u20131060","DOI":"10.1093\/ajcn\/76.5.1055"},{"key":"2021120819252166500_R47","doi-asserted-by":"crossref","unstructured":"Shearer MJ, Bach A, Kohlmeir M. Chemistry, nutritional sources, tissue distribution and metabolism of vitamin K with special reference to bone health. J Nutr.\u20081996;126(suppl):1181S\u20131186S","DOI":"10.1093\/jn\/126.suppl_4.1181S"},{"key":"2021120819252166500_R48","doi-asserted-by":"crossref","unstructured":"Ramsey BW, Farrell PM, Pencharz P, Consensus Committee. Nutritional assessment and management in cystic fibrosis: a consensus report. Am J Clin Nutr.\u20081992;55:108\u2013116","DOI":"10.1093\/ajcn\/55.1.108"},{"key":"2021120819252166500_R49","doi-asserted-by":"crossref","unstructured":"Becker LT, Ahrens RA, Think RJ, et al. Effect of vitamin K1 supplementation on vitamin K status in cystic fibrosis patients. J Pediatr Gastroenterol Nutr.\u20081997;24:512\u2013517","DOI":"10.1097\/00005176-199705000-00003"},{"key":"2021120819252166500_R50","doi-asserted-by":"crossref","unstructured":"Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for paediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr.\u20082002;35:246\u2013259","DOI":"10.1097\/00005176-200209000-00004"},{"key":"2021120819252166500_R51","doi-asserted-by":"crossref","unstructured":"Sinaasappel M, Stern M, Littlewood J, et al. Nutrition in patients with cystic fibrosis: a European consensus. J Cystic Fibrosis.\u20082002;1:51\u201375","DOI":"10.1016\/S1569-1993(02)00032-2"},{"key":"2021120819252166500_R52","unstructured":"Cystic Fibrosis Trust Nutrition Working Group. Nutritional management of cystic fibrosis. London, United Kingdom: Cystic Fibrosis Trust; 2002"},{"key":"2021120819252166500_R53","doi-asserted-by":"crossref","unstructured":"Zittermann A. Effects of vitamin K on calcium and bone metabolism. Curr Opin Clin Nutr Metab Care.\u20082001;4:483\u2013487","DOI":"10.1097\/00075197-200111000-00003"},{"key":"2021120819252166500_R54","doi-asserted-by":"crossref","unstructured":"Feskanich D, Singh V, Willett WC, Colditz GA. Vitamin A intake and hip fractures among post-menopausal women. JAMA.\u20082002;287:47\u201354","DOI":"10.1001\/jama.287.1.47"},{"key":"2021120819252166500_R55","doi-asserted-by":"crossref","unstructured":"Michaelesson K, Lithell H, Vessby B, Melhaus H. Serum retinol levels and the risk of fracture. N Engl J Med.\u20082003;348:287\u2013294","DOI":"10.1056\/NEJMoa021171"},{"key":"2021120819252166500_R56","doi-asserted-by":"crossref","unstructured":"Binkley NC, Krueger D, Engelke JA, Foley AL, Suttie JW. Vitamin K supplementation reduces serum concentrations of under-\u03b3-carboxylated osteocalcin in healthy young and elderly adults. Am J Clin Nutr.\u20082000;72:1523\u20131528","DOI":"10.1093\/ajcn\/72.6.1523"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/5\/1325\/1028483\/zpe00505001325.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/5\/1325\/1028483\/zpe00505001325.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:07:54Z","timestamp":1683072474000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/115\/5\/1325\/67523\/Vitamin-K-Status-Among-Children-With-Cystic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,1]]},"references-count":56,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2005,5,1]]},"published-print":{"date-parts":[[2005,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-1242","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,1]]}}}